| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.4M | +64.9% |
| Cost of Revenue | $7.2M | +64.6% |
| Gross Profit | $194K | +79.6% |
| R&D Expense | $33.0M | +36.7% |
| SG&A Expense | $28.6M | +100.4% |
| Operating Income | -$61.4M | -60.3% |
| Pre-tax Income | $9.4M | +125.2% |
| Income Tax | $16K | -20.0% |
| Net Income | $9.4M | +125.2% |
| EPS (Basic) | $0.06 | +110.9% |
| EPS (Diluted) | $0.06 | +110.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.0M | +774.5% |
| Accounts Receivable | $1.3M | +160.2% |
| Inventory | $3.0M | +18.3% |
| Current Assets | $46.2M | — |
| Total Assets | $50.3M | -70.9% |
| Current Liabilities | $47.0M | +2891.6% |
| Total Liabilities | $48.7M | +246.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.0M | -57.8% |
| Investing Cash Flow | -$1.6M | -105.4% |
| Financing Cash Flow | $88.5M | — |
| Stockholders' Equity |
| $1.6M |
| +111.7% |